Organizational Chart International Technology Transfer General Information Career Opportunities


Spacer

 
Licensing & Royalties
spacer
 

Licensing Opportunities

Technology Abstracts

Print This Abstract Apply Questions ?
Vasostatin as Marrow Protectant

Description of Invention:
This patent relates to the stimulation of hematopoiesis, more specifically to the protection of hematopoietic stem cells from toxic agents, including chemotherapeutic agents and/or irradiation. The subject patent discloses specific fragments of vasostatin, and their application as stimulants of hematopoiesis in vitro and in vivo. Also disclosed is a method for stimulating the proliferation/survival of hematopoietic cells exposed to a chemotherapeutic agent or irradiation using these fragments. In one embodiment, a method is disclosed for stimulating the growth or survival of hematopoietic stem cells with a fragment of vasostatin, in the presence of a growth factor.

Inventors:
Giovanna Tosato et al. (NCI)

Patent Status:
DHHS Reference No. E-230-2000/0-US-01 (U.S. Patent No. 6,596,690 B2 issued 22 Jul 2003)
DHHS Reference No. E-230-2000/0-US-02 filed 01 Apr 2003 (U.S. Patent Application No. 10/405,588)

Portfolios:
Cancer

Cancer -Therapeutics-Biological Response Modifiers
Cancer -Therapeutics-Immunomodulators and Immunostimulants
Cancer -Therapeutics


For Additional Information Please Contact:
Mojdeh Bahar J.D.
NIH Office of Technology Transfer
6011 Executive Blvd, Suite 325
Rockville, MD 20852-3804
Phone: (301)435-2950
Email: baharm@mail.nih.gov
Fax: (301) 402-0220


Web Ref: 827

Updated: 12/03

 

 
 
Spacer